Sep 2026· Current Oncology· Vol 33· 0 citations· 48 references
Medicine
TL;DR
An explainable deep learning model was developed and evaluated, which predicted survival during the first year after radiotherapy with discrimination and calibration comparable to those of a Cox proportional hazards model, indicating that this prognostic information can be provided as a simple bedside score rather than requiring artificial intelligence software.
Abstract
Simple Summary Predicting overall survival after palliative radiotherapy for bone metastases plays a critical role in determining appropriate treatment strategies, including adjusting treatment intensity according to individual patient prognosis. Although machine learning-based survival prediction has been investigated in this setting, explainable deep learning models remain underexplored. Prognostic scores used in this setting add up risk points for individual factors, but whether this simple additive form misses prognostic information had not been tested. This study developed and evaluated an explainable deep learning model, which can capture more complex patterns, using data from 472 patients. The model predicted survival during the first year after radiotherapy with discrimination and calibration comparable to those of a Cox proportional hazards model, indicating that this prognostic information can be provided as a simple bedside score rather than requiring artificial intelligence software. The explainability analyses identified poor performance status as by far the strongest predictor, followed by male sex, high-risk primary tumor type, the burden of metastatic disease, and the planned radiation dose; a higher planned dose was the only leading factor associated with lower predicted mortality. These findings support explainable, individualized survival estimation as an aid to decisions on treatment goals and radiation schedules.
Brain metastases (BM) from renal cell carcinoma (RCC) significantly affect survival, and disease-specific prognostic tools for patients undergoing stereotactic radiosurgery (SRS) remain limited. We aimed to identify prognostic factors and develop an interpretable machine learning (ML) model for individualized ris...
S. Ozgul, Melis Parabas, Peng Li et al.· Neuro-Oncology Practice· 0 citations
Seven survival models representing linear, tree-based, and neural-network techniques were assessed and demonstrated competitive performance compared with published studies, with chemoradiotherapy, extent of resection, MGMT methylation status, age, and performance status identified as the most influential predictors.
Alina Morozova, Elizabeth Ford, Giles Critchley et al.· Neuro-Oncology· 0 citations
BACKGROUND
Patients with lung adenocarcinoma (LUAD) receiving radiotherapy represent an important but underexplored clinical subgroup. These patients often undergo concomitant pharmacologic treatments, yet the prognostic impact and underlying determinants of such combined regimens remain poorly understood.
OBJECTIVE...
Zaishuang Ju, Yu-Tong Wu, Li-Li Tian et al.· Pakistan Journal of Pharmace...· 0 citations
Using structured preoperative clinical data, machine-and deep-learning models to predict overall survival in patients with CRLM are developed and compared to well established Basingstoke Predictive Index.
Nikhil Pramod Kumar, S. Drejian, M. Akhavi et al.· Frontiers in Oncology· 0 citations
The 50-variable DL model provided reasonable prediction and generated clinically plausible feature-importance hypotheses, but it did not demonstrate a clearly meaningful performance advantage over the simpler 5-variable LASSO-based ML model.
S. Ito, Hiroaki Nakashima, N. Segi et al.· Spine· 0 citations
The results show that patients who received chemotherapy demonstrated a shorter median RFS compared to those who did not, and radiotherapy was associated with improved prognosis, in line with meta-analyses showing reduced breast cancer mortality post-radiotherapy.
Boby Al Qurthuby, I. M. Murwantara· International Journal of Adv...· 0 citations
Related blog posts
MIT News · Artificial Intelligence· news.mit.eduNov 2, 2026
The MIT professors collaborated to identify the first AI-discovered antibiotic, a scientific breakthrough that is widely recognized as a milestone in AI-driven drug discovery.
MIT News · Artificial Intelligence· news.mit.eduOct 30, 2026
MIT professors Adam Berinsky and Chara Podimata discuss a new project to track how AI chatbots are responding to questions about the 2026 U.S. midterm elections.